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Abstract
Trypanosoma vivax is one of the causative agents of Animal African Trypanosomosis in cat-
tle, which is endemic in sub-Saharan Africa and transmitted primarily by the bite of the
tsetse fly vector. The parasite can also be mechanically transmitted, and this has allowed its
spread to South America. Diagnostics are limited for this parasite and in farm settings diag-
nosis is mainly symptom-based. We set out to identify, using a proteomic approach, candi-
date diagnostic antigens to develop into an easy to use pen-side lateral flow test device.
Two related members the invariant surface glycoprotein family, TvY486_0045500 and
TvY486_0019690, were selected. Segments of these antigens, lacking N-terminal signal
peptides and C-terminal transmembrane domains, were expressed in E. coli. Both were
developed into ELISA tests and one of them, TvY486_0045500, was developed into a lat-
eral flow test prototype. The tests were all evaluated blind with 113 randomised serum sam-
ples, taken from 37 calves before and after infection with T. vivax or T. congolense. The
TvY486_0045500 and TvY486_0019690 ELISA tests gave identical sensitivity and speci-
ficity values for T. vivax infection of 94.5% (95% CI, 86.5% to 98.5%) and 88.0% (95% CI,
75.7% to 95.5%), respectively, and the TvY486_0045500 lateral flow test prototype a sensi-
tivity and specificity of 92.0% (95% CI, 83.4% to 97.0%) and 89.8% (95% CI, 77.8% to
96.6%), respectively. These data suggest that recombinant TvY486_0045500 shows prom-
ise for the development of a pen-side lateral flow test for the diagnosis of T. vivax animal
African trypanosomosis.
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Author Summary
African Animal Trypanosomosis presents a significant problem for agricultural develop-
ment in sub-Saharan Africa and leads to large economic losses. One of the main parasites
responsible is Trypanosoma vivax. Current diagnostic methods are either symptom-based
or too costly and technologically demanding for use in endemic regions. Here, we identi-
fied T. vivax proteins selectively recognized by infected cattle sera and developed two
related proteins into ELISA tests and one of these into a lateral flow test prototype. All
three tests performed well when tested against randomised calf sera, suggesting good
potential for the development of a pen-side T. vivax animal African trypanosomosis diag-
nostic device for use in endemic regions.
Introduction
Trypanosoma vivax is a protozoan parasite of the genus trypanosomatidae spread primarily by
biting insects. Together with T. brucei and T. congolense, it is a causative agent of Animal Afri-
can Trypanosomosis (AAT) in cattle. T. vivax causes a severe version of AAT, often character-
ised by hemorrhagic fever as well as the more typical weight loss, fatigue and anaemia [1].
As T. vivax does not require midgut gestation within the vector it can be can be transmitted
mechanically by body fluid contamination and hematophagous flies [2,3]. This has allowed the
spread of the disease in South America, an area previously free from T. vivax. Over eleven mil-
lion cattle are estimated to be at risk in this region [4] in addition to the 46 million cattle at risk
in sub-Saharan Africa [5].
Diagnostics are limited for this parasite, relying principally on microscopy, specific antibody
detection using whole parasite lysates as target antigen [6] or PCR that requires specialised
equipment [7,8]. Recently, the use of heterologous soluble form variant surface glycoproteins
(VSGs), such as T. evansi RoTat1.2 and T. equiperdum p64, as cross-reactive diagnostic anti-
gens for T. vivax cattle infections has been described [9] and these may lead to new diagnostic
tools. Nevertheless, at the moment, farmers mostly rely upon symptom-based diagnosis, which
is complicated by the numerous other diseases with similar manifestations in the endemic
regions.
With this in mind, we set out to develop a low-cost pen-side diagnostic test for T. vivax
infections in cattle using lateral flow test (LFT) technology. We used the approach of identify-
ing parasite antigens selectively recognised by cattle infection sera by proteomics, followed by
recombinant protein expression in E. coli and antigen assessment by ELISA to select an antigen
for LFT prototyping. This general approach has been successful for selecting diagnostic anti-
gens for human T. brucei gambiense and cattle T. congolense infections [10–12]. One of these
antigens, a recombinant invariant surface glycoprotein (rISG65-1), has been selected by the
Foundation for Innovative New Diagnostics (FIND) for development of a next-generation ‘all
recombinant’ LFT for human African trypanosomiasis.
Here, we report the identification, recombinant production and evaluation by ELISA of seg-
ments of two related invariant surface glycoprotein (ISG) diagnostic antigens for AAT caused
by T. vivax, and the generation and evaluation of a prototype LFT with one of them.
Materials and Methods
Ethics statement
Rodents were used to propagate sufficient T. vivax parasites to make the detergent lysates for
immunoaffinity chromatography and proteomics. The animal procedures were carried out
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according the United Kingdom Animals (Scientific Procedures) Act 1986 and according to spe-
cific protocols approved by The University of Dundee Ethics Committee and as defined and
approved in the UK Home Office Project License PPL 60/3836 held by MAJF.
Cattle studies were approved by the ClinVet IACUC which complies with The South Afri-
can National Standard: SANS 10386:2008: The care and use of animals for scientific purposes.
Sera
All sera were provided by GALVmed. The sera used for the antigen identification by immuno-
precipitation and proteomics were from four animals obtained commercially in Burkina Faso
and treated prophylactically for T. vivax infections before experimental infection with T. vivax.
Further sera, including 113 samples for ELISA and LFT blind testing, were obtained from Bur-
kina Faso, Mozambique and South Africa, the latter were all from cattle raised under fly-nets.
Of the 113 sera for blind testing: The Burkina Faso samples (21 sera) were from 4 calves and
consisted of 4 pre-infection and 17 T. vivax post-infection sera. The Mozambique samples (20
sera) were from 2 calves and consisted of 20 T. vivax post-infection sera. The South Africa
(ClinVet) samples (72 sera) were from 31 calves and consisted of 27 pre-infection and 32 T.
vivax post-infection sera and 13 T. congolense post-infection sera. Strains used to infect cattle
(one isolate per calf) were: In Mozambique, Y486 and IL700. In Burkina Faso, Sokoroni 18,
Napie22, Komborodougou and Gondo Bengaly. At ClinVet, ILRAD560.
IgG purification from pre- and post-infection sera
Sera were collected in Burkina Faso from four calves before and 28 days after experimental
infection with T. vivax. Aliquots (250 μl) of the pre- and post-infection sera were pooled and
IgG fractions were purified on protein-G Sepharose, as previously described [11, 13]. Purified
IgG was coupled to CNBr-activated Sepharose 4B (GE Healthcare) at 4 mg IgG per milliliter of
packed gel, according the manufacturer’s instructions.
Preparation of T. vivax parasite lysate
Three BALB/c mice were injected with one stabilate of T. vivax ILRAD V34. After five days,
infected mouse blood was harvested with citrate anticoagulant, adjusted to 5×104 parasites per
ml with phosphate-buffered saline (PBS) and aliquots of 0.2 ml were injected into the perito-
neal cavity of 45 NMR1 mice. The mouse blood was harvested after 7 days and the parasites
were purified by centrifugation, to yield a buffy coat enriched in trypanosomes, followed by
DE52 ion exchange chromatography to remove white blood cells and residual erythrocytes, as
described in [11, 13]. The purified trypanosomes were dissolved at 1 x 109 cells.mL-1 in 50 mM
sodium phosphate buffer, pH 7.2, 2% n-octyl-β-D-glucopyranoside (nOG) detergent contain-
ing 1X Roche protease cocktail minus EDTA as well as 1 mM phenylmethylsulfonyl fluoride
(PMSF), 0.1 mM N-p-tosyl-L-lysine chloromethyl ketone (TLCK), 1 μg.mL-1 leupeptin and
aprotinin. The latter protease inhibitor cocktail is efficient in protecting trypanosome proteins
from proteolysis in detergent lysates for immunoprecipitation [14]. The lysate was incubated
for 30 min on ice and then centrifuged at 100,000 g for 1 h at 4°C.
Immunoprecipitation
Aliquots of T. vivax detergent lysate (10 ml) were incubated with 0.75 ml packed volume of
each of the 4 mg.ml-1 Sepharose-IgG (infection and non-infection/control) gels, rotating for 3
h at 4°C. The gels were then packed into disposable 10 ml columns and washed with 10 ml of
10 mMNa2PO4, pH 7.2, 200 mMNaCl, 1% nOG, followed by 10 ml of 5 mM Na2PO4 pH 7.2,
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1% nOG. The trypanosome proteins were eluted with 500 μl of 50 mM sodium citrate, pH 2.8,
1% nOG into tubes containing 100 μl of 1 M Tris pH 8.5 for neutralization. The eluates were
further concentrated to 270 μl using a centrifugal concentrator (Millipore, 0.5 ml capacity with
10 kDa MW cut off membrane). The concentrates containing the trypanosome proteins were
then transferred to low binding Eppendorf tubes and the proteins precipitated by adding 1 ml
ice-cold ethanol and incubation for 24 h at −20°C.
Proteomic protein identification
Following ethanol precipitation, the proteins eluted from the post-infection IgG and pre-infec-
tion IgG columns were dissolved in SDS sample buffer, reduced with DTT and run on a precast
4–12% Bis-Tris gradient SDS-PAGE (Invitrogen) using the MES running system. The gel was
stained with colloidal Coomassie blue and equivalent regions of the infection and control lanes
were cut out, reduced and alkylated with iodoacetamide and digested in-gel with trypsin. The
tryptic peptides were analysed by LC-MS/MS on a Thermo Orbitrap Velos system and Max-
Quant 1.4 software was used to match peptides to the predicted trypanosome protein databases
[15]. Where possible, annotated gene names, or the names of homologues identified using
BLASTp [16] or the protein fold/family identified with Pfam [17], were used (S1 Table). The
programMaxQuant 1.4 was also used to obtain relative intensity data of the peptides recovered
from the post-infection and pre-infection (control) IgG columns.
Cloning
A DNA construct encoding residues 42–363 of TvY486_0019690 was amplified from T. vivax
(strain ILRAD V34) genomic DNA using the forward and reverse primers 5’-CATATGGAGA
ATGAGATTGCTCGGG-3’ and 5’-GGATCCAATGCTGAGTTTGCTATTGTTAGCTGA-3’,
respectively, where the underlined bases are the Nde1 and BamH1 cloning restriction sites. The
gene TvY486__0045500, which is very similar in sequence to TvY486_0019690, could not be
selectively amplified and a construct encoding residues 40–363 was instead synthesised by
GenScript and optimised to avoid rare codon combinations in E. coli, unfavourable mRNA
structures for protein expression and cis elements. The gene was obtained in a pUC vector with
restriction sites (Nde1 and BamH1) in place for downstream cloning. Both constructs were
ligated into pCR2.1-TOPO using the TOPO TA Cloning Kit (Invitrogen) and then inserted
into a pET15b-derived plasmid (Novagen) modified to include a tobacco etch virus (TEV) pro-
tease cleavage site between the N-terminal hexahistidine affinity tag and the protein sequence
of interest. Recombinant gene expression of the TvY486_0045500 construct was achieved with E.
coli BL21-CodonPlus (DE3) RIPL cells (Stratagene) in autoinduction medium [18] containing
50 μg mL-1 ampicillin and 12 μg mL-1 chloramphenicol. The construct for TvY486_0019690 was
expressed in BL21 (DE3) Gold cells (Stratagene) in autoinduction medium containing 50 μg mL-1
ampicillian. Cells were cultured for 24 h at 22°C before harvesting by centrifugation (3,500 x g,
30 min, 4°C) the bacterial pellet was resuspended in buffer A (50 mMTris-HCl, pH 7.5, 250 mM
NaCl) containing an EDTA-free protease inhibitor cocktail (Roche).
Protein purification of recombinant proteins
Purification was achieved using the methods described in [19]. Briefly, E. coli cells were
mechanically lysed in the presence of DNAse than clarified by centrifugation (4°C, 40 min,
30,000 g). The proteins were captured using a 5 ml immobilised metal affinity chromatography
(IMAC) (HisTrap GE Healthcare) and eluted with an imidazole gradient. Affinity tags were
removed, via proteolytic cleavage (1 mg His6-TEV protease per 20 mg protein, 4 ˚C, 16 h) and
the protein dialysed into buffer A (50 mM Tris-HCl, pH 7.5, 250 mMNaCl). The protease,
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uncleaved protein and affinity tag contaminants were removed with a further subtractive
IMAC step. Final purification was achieved by size exclusion chromatography (Superdex 200
26/60) eluted with buffer A. Finally, proteins were dialysed into PBS and adjusted to at least 1
mg.ml-1 using 10 kDa cut-off centrifugal concentrators. All proteins were>95% pure, as
judged by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) and Coo-
massie blue staining.
Enzyme linked immunosorbent assay (ELISA)
White polystyrene Costar untreated 96 well plates were coated with 50 μl per well of target pro-
tein at a concentration of 2μg mL-1 in plating buffer (0.05 M NaHCO3, pH 9.6) then blocked
with 200 μl of PBS containing 5% bovine serum albumin (BSA) and 0.1% Tween-20 overnight
at 4°C. Calf sera were diluted 1:2500 in PBS containing 5% BSA, 0.1% Tween-20 and trans-
ferred in triplicate by a liquid handling device (Bio-Tek, Precision) to the ELISA plates and
incubated for 1h at room temperature. After 1 h the diluted sera were aspirated and the wells
were washed with PBS containing 0.1% BSA with the liquid handling device. This wash cycle
was repeated 5 times. Biotinylated anti-bovine-IgG (Jackson labs) was added at dilution of
1:4000 (50 μl per well) and incubated for 1 h. Excess anti-bovine-IgG antibody was washed
away (as described before) and 50 μl per well of ExtrAvidin-Horse Radish Peroxidase (HRP) at
a dilution of 1:4000 was added to the plates and incubated for 1 h. The solution was aspirated
and the wash steps were repeated. Finally, chemiluminescent super signal Femto substrate
(Pierce) diluted 1:5 (i.e., 0.5 ml solution A, 0.5 ml solution B with 4 ml PBS) was applied to the
wells at 50 μl per well and plates were read using an Envision plate reader within 5 minutes of
addition of the substrate.
Prototype lateral flow test manufacture and use
Purified recombinant TvY486_0045500 residues 40–363 (7.5 mg) were provided to BBI-Solu-
tions, an immunoassay development and manufacturing company that has completed more
than 250 lateral flow projects over the last 25 years, with manufacturing sites in Europe, USA
and South Africa, and 2400 prototype LFT devices were manufactured.
The LFT is comprised of a sample pad, conjugate pad, nitrocellulose strip and top pad all
attached to a backing card and housed within a plastic cassette. The sample is applied to the
sample pad (followed by a chase buffer) that then flows onto the conjugate pad which contains
2 gold conjugates, a test conjugate that has p310 antigens bound to gold colloid, and a control
conjugate that has an irrelevant (for the p310 detection system) antibody bound to gold colloid.
The sample flows up the test strip and solubilizes the gold conjugates which then flow up the
assay on to a nitrocellulose strip that has a p310 antigen line striped at the test line position. If
it is a positive sample, anti-p310 antibodies within the sample will bind the p310 antigen test
line and will have also bound the p310 antigen gold conjugate. This results in the p310 antigen
gold conjugate being localized at the test line, due to a p310 antigen-anti p310 antibody-p310
antigen “sandwich” binding reaction. The accumulation of the gold conjugate will eventually
become visible to the end user if the sample contains sufficient anti-p310 antibodies. If the
sample is negative there will be no anti-p310 antibodies present and so no accumulation of
gold colloid at the test line and so a test line will not appear. The sample/conjugate solution
will flow past the test line and the irrelevant gold conjugate will bind at a control line and form
a visible line, which is specific to the irrelevant gold conjugate, thus demonstrating successful
flow of the sample and conjugates up the lateral flow assay. The sample/conjugates will then
move in to the top pad of the lateral flow assay that ensures the solution flows unidirectionally
along the assay.
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Triplicate aliquots of 5 μl of calf sera diluted with 15 μl of PBS were added to the LFTs fol-
lowed by an 80 μl of chase-buffer (PBS containing 0.05% Tween 20). Tests were discarded if
upper control line was not clearly visible. After 30 min, scoring of the test bands was performed
by visual comparison of freshly completed tests with a scoring card [20] (S2 Fig) and the con-
sensus score from three devices for each serum was recorded. After reading, the nitrocellulose
test strips were taken out their cases for photography.
Results
Selection of candidate diagnostic antigens for T. vivax
An immunoprecipitation experiment was carried out to identify candidate diagnostic antigens
for T. vivax. Pooled pre-infection (day -7) and post-infection (day +28) calf sera from four ani-
mals from Burkina Faso were used to generate IgG antibody columns. Detergent lysate of
bloodstream form T. vivax cells was generated from parasites recovered from mice infected
with T. vivax strain ILRAD V34. Identical amounts of parasite detergent lysate were mixed
with the pre-infection and post-infection Sepharose-IgG beads and proteins bound to the
washed beads were eluted with low pH to break antibody-antigen interactions. The eluted sam-
ples from the pre-infection and post-infection columns were concentrated and subjected to
SDS-PAGE gels for antigen separation. The pre-infection and post-infection eluates were run
on separate SDS-PAGE gels to reduce potential antigen cross-contamination. The Coomassie
blue stained gel lanes were cut into ten segments and each subjected to in-gel reduction and
alkylation and trypsin digestion. The peptides from each gel slice were separately analysed by
LC-MS/MS and the data concatenated for the pre-infection and post-infection eluate samples,
respectively. These concatenated data sets were used to search the predicted protein database
for T. vivax (Y486) using MaxQuant 1.4.
Many proteins (>1300) were identified in the combined data from each of the Sepharose-
IgG eluates. However, the protein identification lists were sorted to select for proteins found
either uniquely in the post-infection Sepharose-IgG eluate or that were>10 fold enriched in
the post-infection Sepharose-IgG column eluate, as judged using the label-free quantification
function in MaxQuant 1.4 [21], (S1 Table). Of the twenty-three proteins unique to the post-
infection IgG eluate, all had low LC-MS/MS intensities suggesting that the immune response to
these antigens, while specific, was low [10, 11]. Eleven proteins had infection: control intensity
ratios>10. Two of these stood out as possible immunodiagnostic antigens, TvY486_0045500
and TvY486_0019690. These are two closely related proteins sharing 91% and 80% amino acid
sequence similarity and identity, respectively. These proteins have a typical ISG domain struc-
ture, consisting of an N-terminal signal peptide, an ISG domain, a transmembrane domain and
a small intracellular domain [22]. We chose to investigate these antigens because ISGs have
previously proved to be good diagnostics antigens for T. brucei, T. congolonse and T. evansi
[10–12].
Expression and evaluation of recombinant T. vivax ISG antigens
Similar segments of TvY486_0045500 (amino acid residues 40–363) and TvY486_0019690
(amino acid residues 42–363), avoiding the N-terminal signal peptides and C-terminal trans-
membrane domains, were cloned and expressed with cleavable hexa-histidine tags in E. coli.
Following nickel affinity purification and proteolytic cleavage of the hexa-histidine tags, mono-
disperse forms of both proteins collected from a subsequent gel-filtration purification step
(and separated from aggregated material appearing at the void volume) with a final yield of 0.6
mg.L-1 for TvY486_0019690 and 4 mg.L-1 for TvY486_0045500. The predicted amino acid
sequences of the two recombinant proteins are shown in (S1 Fig).
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The two purified recombinant proteins were used to coat ELISA plates and tested with the
sera of 14 calves that had been collected pre- (day -7) and post- (day +28) experimental infec-
tion with T. vivax at the ClinVet site. These data (Fig 1) indicated that both recombinant
TvY486_0045500 and TvY486_0019690 coated ELISA plates could discriminate infected from
uninfected sera.
TvY486_0045500 (residues 40–363) was selected for the manufacture of a prototype lateral
flow device, because of its relative ease of protein expression, and was supplied to BBI Solutions
(Dundee, http://www.bbisolutions.com/).
Both the TvY486_0045500 and TvY486_0019690 coated ELISA plates, and the
TvY486_0045500 LFT prototype, were tested in triplicate with 113 randomised cattle sera pro-
vided by GALVmed. After data collection, the sera codes were broken and the data are collated
in (S2 Table). Sera were classified as being either from uninfected animals or from animals that
had been exposed to experimental T. vivax infection. Based on this classification, there were 69
infection (positive) and 44 control (negative) sera. Cut-off values for maximum positive/nega-
tive discrimination were determined (600,000 and 1,100,000 units for the TvY486_0045500
and TvY486_0019690 ELISA plates, respectively, and> = 2 units for the LFT) and, using these
Fig 1. ELISA data of recombinant proteins TvY486_0045500 and TvY486_0019690 against pooled T. vivax
sera from calves before (day-7) and after infection (day+28).
doi:10.1371/journal.pntd.0004977.g001
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cut-offs, the sensitivity and specificity data were determined (Table 1). Representative LFT data
are shown in (Fig 2) and the results of all 113 tests are shown in (S2 Fig).
Discussion
In this study, we used quantitative proteomics to identify candidate diagnostic antigens, i.e.,
those proteins in whole T. vivax detergent lysate that bound selectively (>10 fold more) to the
immobilised IgG from calves experimentally infected for 28 days with T. vivax versus immobi-
lised IgG from the same animals collected 7 days prior to experimental infection. In total, we
found 34 candidate protein groups but rejected most of these based on the low intensities of
their combined peptide ions in the LC-MS/MS analyses (we interpret low peptide intensities as
an indication that only a small proportion of infection-specific IgG is directed towards their
parent antigens [10,11]). The two proteins that produced the most intense peptides, and signif-
icant (around 30-fold) enrichment, were two related ISGs. We therefore focussed on these pro-
teins and made recombinant versions in E. coli that lack the predicted cleavable N-terminal
signal peptides and the predicted C-terminal transmembrane and short cytoplasmic domains.
Both recombinant proteins were immunoreactive with pooled T. vivax infection sera and both
antigens were subsequently tested in ELISA format against 113 randomised calf sera and found
to have identical overall performance in terms of sensitivity and specificity (Table 1). Further,
the Pearson coefficient between the two ELISA data sets was 0.9876, indicating that there is
nothing to choose between the two antigens with respect to immunodiagnostic potential. The
antigen that expressed most efficiently in E. coli (TvY486_0045500) was used to make a proto-
type LFT device and this was also tested blind with the same 113 randomised sera. Upon break-
ing the code, it became clear that we could obtain maximum discrimination between T. vivax
positive and negative sera by setting the visual score cut-off at> = 2 (Fig 2) and, using these
criteria, the sensitivity and specificity of the prototype LFT was similar to that of the ELISA
(Table 1). These are promising performance results considering that the prototype LFT was
not optimised with respect to antigen density on the test strip, antigen-gold conjugation or
chase-buffer composition which, individually or collectively, should allow a reduction in back-
ground (false positive) scores of 0.5 and 1 for some sera.
Of note is that 13 of the T. vivax negative sera were from calves experimentally infected with
T. congolense. None of these 13 sera gave a positive reaction with the T. vivax ISGs, either by
ELISA or LFT, suggesting that the T. vivax ISGs do not routinely cross-react with T. congolense
infection sera. This lack of cross-reactivity with T. congolense (and likely with other trypano-
some species such as T. b. brucei) is expected, given that BLASTp [15] searches with the
TvY486_0045500 predicted amino acid sequence does not return any significant hits against
trypansomatid predicted protein databases, other than for T. vivax, [15, 22]. This is in contrast
to, for example, the GM6 antigen (also recently developed into an LFT) that cross-reacts with
the sera from cattle infected with multiple trypanosome species [23,24]. Both of these proper-
ties are useful, the latter with respect to making a pan-specific cattle AAT diagnostic and the
former as a component of a pathogen-identifying diagnostic. It is also worth noting that
BLASTp searches with the TvY486_0045500 predicted amino acid sequence does not return
Table 1. Sensitivity and specificity data for T. vivax ISG ELISAs and prototype LFT.
Test Sensitivity 95% CI Speciﬁcity 95% CI
TvY486_0045500 ELISA 94.5% 86.5% to 98.5% 88.0% 75.7% to 95.5%
TvY486_0019690 ELISA 94.5% 86.5% to 98.5% 88.0% 75.7% to 95.5%
TvY486_0045500 LFT 92.0% 83.4% to 97.0% 89.8% 77.8% to 96.6%
doi:10.1371/journal.pntd.0004977.t001
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significant hits against any predicted protein databases, other than for T. vivax, suggesting that
cross-reactivity with other non-trypanosomatid cattle pathogens is also unlikely.
Fig 2. Examples of the TvY486_0045500 prototype lateral flow tests developed with control and
infection sera, as indicated. Top band control line, bottom band TvY486_0045500 diagnostic line.
doi:10.1371/journal.pntd.0004977.g002
A Diagnostic for T. vivax
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Supporting Information
S1 Fig. Predicted amino acid sequences of the recombinant ISG domains used in this study.
The amino acids highlighted in italics (GHM) come from the cleaved TEV site.
(PDF)
S2 Fig. Scans of the triplicate LFT analyses of the 113 randomised sera. Randomised serum
numbers (see S2 Table for details) are indicted below each group of three LFT nitrocellulose
strips that have been removed from their plastic casings. The score card used to score the inten-
sities of the test bands is also shown. Notes: Serum samples 29 and 108 have only duplicate
LFT analyses and the samples marked ‘blank’ and ‘X’ are negative control samples developed
without serum.
(PDF)
S1 Table. Quantitative proteomics results. The antigens are ordered by their infection: con-
trol LC-MS/MS intensity ratios and color coded according to their absolute LC-MS/MS inten-
sities: black bold>1000; black> 500; grey>10.
(PDF)
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